CD8+ CD19-CAR-T cells eliminated B cells, reduced circulating IgM, IgG, and pathogenic anti-DNA antibodies as well as reduced the ratio of CD4/CD8+ T cells in murine models of SLE. Here, CD19 is linked to systemic lupus erythematosus.